In a sign of strong demand, TransS1, a provider of minimally invasive devices to treat lower back disc disease, priced its 5.5 million share offering at $15, above the proposed $12-$14 range. With solutions that claim to have the shortest surgery durations,...read more
Trans1, medical device company developing products to treat spinal disease, filed terms Friday with the SEC for its upcoming IPO. The company plans to offer 5.5 million shares at a price range of $12 to $14 per share. Lehman Brothers and Piper Jaffray are the...read more
Worst weekly performers: TranS1, Bridgepoint Education, Noah Education Holdings
The following companies were the worst performing IPOs over the last five trading sessions:
...read more
Worst weekly perfomers: Encore Bancshares, TranS1, SandRidge Energy
The following companies were the worst performing IPOs over the last five trading sessions:
...read more
Spinal therapy play TransS1 prices shares above range
In a sign of strong demand, TransS1, a provider of minimally invasive devices to treat lower back disc disease, priced its 5.5 million share offering at $15, above the proposed $12-$14 range. With solutions that claim to have the shortest surgery durations,...read more
Medical device company Trans1 announces terms
Trans1, medical device company developing products to treat spinal disease, filed terms Friday with the SEC for its upcoming IPO. The company plans to offer 5.5 million shares at a price range of $12 to $14 per share. Lehman Brothers and Piper Jaffray are the...read more